Taysha Gene Therapies, Inc. (TSHA) Free Cash Flow
Taysha Gene Therapies, Inc. (TSHA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$30.81M |
| 2021-12-31 | -$138.60M |
| 2022-12-31 | -$113.26M |
| 2023-12-31 | -$80.39M |
| 2024-12-31 | -$81.60M |
| 2025-12-31 | -$93.83M |
How TSHA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AGEN | Agenus Inc. | -$77.20M |
| QDEL | QuidelOrtho Corp Com | -$83.00M |
| INO | Inovio Pharmaceuticals Inc. | -$88.92M |
| AXSM | Axsome Therapeutics Inc. | -$93.89M |
| VNDA | Vanda Pharmaceuticals Inc. | -$110.44M |
These are five companies in the same sector as TSHA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("TSHA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TSHA | $5.97 | -1.97% | 2.59M |
| 3 | ||||
| 4 | ||||
| 5 |